
Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Deep Brain Stimulators), Device (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Applicati
Description
Electroceuticals/Bioelectric Medicine Market by Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Deep Brain Stimulators), Device (Implantable Electroceutical Devices, Noninvasive Electroceutical Devices), Application, End-User - Global Forecast 2024-2030
The Electroceuticals/Bioelectric Medicine Market size was estimated at USD 25.06 billion in 2023 and expected to reach USD 27.05 billion in 2024, at a CAGR 8.11% to reach USD 43.28 billion by 2030.
Electroceuticals, or bioelectric medicine, refer to a therapeutic modality that uses electrical impulses to modulate the body's neural circuits as an alternative to pharmaceuticals. This innovative approach exploits the nervous system's inherent capability to govern the body's organ functions, influencing various physiological and pathological conditions. The fundamental principle behind electroceuticals involves precisely delivering electrical signals to specific nerves, aiming to adjust their activity to treat various medical conditions. The growing elderly population, the prevalence of cardiac and neurological disorders, and the rising preference for non-invasive treatments drive the growth of the electroceuticals or bioelectric medicine market. However, the technological complexities associated with electroceuticals hinder their adoption. The ongoing innovation in bioelectric medicine, including the miniaturization of devices and improvements in battery life, and advancements in bioelectric medicine that allow for personalized treatment plans offer lucrative opportunities for the expansion of the electroceuticals or bioelectric medicine market.
Please Note: PDF & Excel + Online Access - 1 Year
Table of Contents
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing prevalence of cardiac and neurological disorders
- 5.1.1.2. Increasing preference for non-invasive treatments
- 5.1.1.3. Rising miniaturization and biocompatibility of electroceutical devices to enhance patient comfort
- 5.1.2. Restraints
- 5.1.2.1. High costs associated with electroceutical treatment
- 5.1.3. Opportunities
- 5.1.3.1. Integration of wireless technologies to improve the functionality and user experience of electroceutical devices
- 5.1.3.2. Rising personalization of electroceutical therapies based on individual patient profiles
- 5.1.4. Challenges
- 5.1.4.1. Technological complexities associated with the electroceuticals
- 5.2. Market Segmentation Analysis
- 5.2.1. Product: Increasing need for cardiac pacemakers and implantable cardioverter defibrillators owing to the prevalence of cardiovascular diseases
- 5.2.2. Application: Growing adoption of electroceuticals to manage chronic pain conditions
- 5.3. Market Disruption Analysis
- 5.4. Porter’s Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
- 5.5. Value Chain & Critical Path Analysis
- 5.6. Pricing Analysis
- 5.7. Technology Analysis
- 5.8. Patent Analysis
- 5.9. Trade Analysis
- 5.10. Regulatory Framework Analysis
- 6. Electroceuticals/Bioelectric Medicine Market, by Product
- 6.1. Introduction
- 6.2. Cardiac Pacemakers & Implantable Cardioverter Defibrillators
- 6.3. Cochlear Implants
- 6.4. Deep Brain Stimulators
- 6.5. Retinal Implants
- 6.6. Spinal Cord Stimulators
- 6.7. Vagus Nerve Stimulators
- 7. Electroceuticals/Bioelectric Medicine Market, by Device
- 7.1. Introduction
- 7.2. Implantable Electroceutical Devices
- 7.3. Noninvasive Electroceutical Devices
- 8. Electroceuticals/Bioelectric Medicine Market, by Application
- 8.1. Introduction
- 8.2. Arrhythmia
- 8.3. Chronic Pain
- 8.4. Epilepsy
- 8.5. Parkinson’s Disease
- 8.6. Retinitis Pigmentosa
- 8.7. Sensorineural Hearing Loss
- 9. Electroceuticals/Bioelectric Medicine Market, by End-User
- 9.1. Introduction
- 9.2. Ambulatory Centers
- 9.3. Home Care Settings
- 9.4. Hospitals & Clinics
- 10. Americas Electroceuticals/Bioelectric Medicine Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Electroceuticals/Bioelectric Medicine Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Electroceuticals/Bioelectric Medicine Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. Market Share Analysis, 2023
- 13.2. FPNV Positioning Matrix, 2023
- 13.3. Competitive Scenario Analysis
- 13.3.1. FDA Approved Medtronic's Percept RC Deep Brain Stimulation (DBS) system
- 13.3.2. Evren Technologies launched the Phoenix 100 taVNS Research System
- 13.3.3. FDA Clears Abbott's Innovative Spinal Cord Stimulation Devices for Chronic Back Pain Patients
- 13.4. Strategy Analysis & Recommendation
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.2. Key Product Portfolio
- FIGURE 1. ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET RESEARCH PROCESS
- FIGURE 2. ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET DYNAMICS
- FIGURE 7. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
- FIGURE 8. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY DEVICE, 2023 VS 2030 (%)
- FIGURE 10. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY DEVICE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. GLOBAL ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 24. ELECTROCEUTICALS/BIOELECTRIC MEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
Pricing
Currency Rates